Since Anavex is presenting results of the trial on Saturday, December 10, 2016, then you will have plenty of time to review the presentation on make an informed decision whether you should buy, sell or hold your shares by monday morning Dec. 12, 2016.
Key things to consider:
What is meant by the term "Exploratory Efficacy" in the title of the Anavex presentation 9-Months and 12-Months Safety and Exploratory Efficacy Data of ANAVEX 2-73 in a Phase 2a Study in Mild-to-Moderate Alzheimer’s Disease Patients ?
December 10, 2016 is the last day of the CTAD Meeting. Conferences often schedule the best and/or the most anticipated presentations for the last.
Food for thought.
Good luck and GOD bless,
George
Market Data 
Markets 
AI
